The role of 18F-FDG PET/CT imaging in Waldenstrom macroglobulinemia (Q39738249)

14 September 2017

The role of 18F-FDG PET/CT imaging in Waldenstrom macroglobulinemia (English)

1 reference

14 September 2017

7

Xavier Leleu

0 references

Irene Ghobrial

11

object named as

Irene M Ghobrial

1 reference

14 September 2017

Ranjit Banwait

1

1 reference

14 September 2017

Kevin O'Regan

2

1 reference

14 September 2017

Federico Campigotto

3

1 reference

14 September 2017

Brianna Harris

4

1 reference

14 September 2017

Dilek Yarar

5

1 reference

14 September 2017

Meghan Bagshaw

6

1 reference

14 September 2017

Renee Leduc

8

1 reference

14 September 2017

Nikhil Ramaiya

9

1 reference

14 September 2017

Edie Weller

10

1 reference

14 September 2017

1 July 2011

1 reference

American Journal of Hematology

14 September 2017

1 reference

14 September 2017

86

1 reference

14 September 2017

7

1 reference

14 September 2017

567-572

1 reference

How I treat Waldenström macroglobulinemia

14 September 2017

1 reference

Current treatment options for Waldenström macroglobulinemia

21 January 2018

1 reference

Waldenström macroglobulinemia

21 January 2018

1 reference

Waldenström macroglobulinaemia.

21 January 2018

1 reference

Uniform response criteria in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia

21 January 2018

1 reference

Update on recommendations for assessing response from the Third International Workshop on Waldenstrom's Macroglobulinemia

21 January 2018

1 reference

Waldenström macroglobulinemia: MR imaging of the spine and CT of the abdomen and pelvis.

21 January 2018

1 reference

Scintigraphic pattern of skeletal involvement of Waldenström macroglobulinemia

21 January 2018

1 reference

Prognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemia

21 January 2018

1 reference

Early therapeutic response assessment by (18)FDG-positron emission tomography during chemotherapy in patients with diffuse large B-cell lymphoma: isolated residual positivity involving bone is not usually a predictor of subsequent treatment failure.

21 January 2018

1 reference

Positron emission tomography (PET) for staging low-grade non-Hodgkin's lymphomas (NHL).

21 January 2018

1 reference

Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL).

21 January 2018

1 reference

Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma

21 January 2018

1 reference

Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia

21 January 2018

1 reference

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

21 January 2018

1 reference

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group

21 January 2018

1 reference

Early therapy monitoring with FDG-PET in aggressive non-Hodgkin?s lymphoma and Hodgkin?s lymphoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/AJH.22044

1 reference

14 September 2017

1 reference